Early Access — free while we kick the tires
EdgarHawk

Edwards Larry Todd

See Remarks

Officer
1 filing analyzed · 1 company · Latest 2024-12-03

Companies

Company Buys Sells Direction
Arcutis Biotherapeutics, Inc. ARQT 1 0 Net buying

Activity

December 2024
high
Buy
1,093 shares
$7,767
Significance 7/10

Edwards bought 1,093 shares of ARQT at $7.11 on 2024-11-30; cluster buy pattern with 2 other insiders in 14 days.

Edwards Larry Todd purchased 1,093 shares at $7.11, adding to a substantial existing position of 136.6K shares and raising it to 137.7K shares. This transaction occurs within a cluster pattern where 2 other insiders also bought ARQT within the past 14 days, suggesting coordinated or at least aligned insider activity. The purchase price of $7.11 is notably below the current price of $12.27 and well below the 52-week high of $13.04, representing acquisition at a depressed level relative to recent market levels. Context is important: despite explosive annual revenue growth of +1517.1%, the company posted a net loss of $-41.5M on quarterly revenue of $44.8M, with full-year net income negative, indicating ARQT remains unprofitable and faces significant operational challenges despite top-line expansion.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access